COMMUNIQUÉS West-GlobeNewswire

Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
27/07/2026
Dr. Rooney, former immunology leader at Johnson & Johnson, will lead clinical development strategy across Kymera’s industry-leading oral immunology portfolio Jared Gollob, MD, will retire from his role after eight [...]
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
27/07/2026
SOUTH SAN FRANCISCO, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the second quarter ended June 30, [...]
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
27/07/2026
CARLSBAD, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions today announced [...]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
27/07/2026
RADNOR, Pa., July 27, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
27/07/2026
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, August 10, 2026, at 4:30 p.m. Eastern Time to report [...]
Atalante X, Wandercraft’s Self-Balancing Rehabilitation Exoskeleton, Receives ARCSA Clearance in Ecuador, Advancing Latin American Expansion
27/07/2026
Clearance broadens access to hands-free, overground robotic gait training in Ecuador, and supports Wandercraft’s plans to expand advanced rehabilitation technology across Latin America NEW YORK and QUITO, Ecuador, July [...]
Philips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refund
27/07/2026
July 27, 2026 Q2 2026 Group performance Comparable order intake declined 1%, due to timing of certain large orders Group sales of EUR 4.4 billion, reflecting 4% comparable sales growth Income from operations of EUR 609 [...]
ORYZON Reports Financial Results and Corporate Update for Half Year Ended June 30th, 2026
27/07/2026
Positive clinical data presented at EHA for iadademstat in first line acute myeloid leukemia (AML); iadademstat+azacitidine+venetoclax resulted in 100% ORR, 89% CRc and 78% CR, including in patients with TP53 or RAS [...]
Elevar Therapeutics Announces Three Abstracts Accepted for Presentation at ESMO Congress 2026
27/07/2026
FORT LEE, N.J., July 27, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2026
27/07/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 20th July to 24th July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 30 - 2026
27/07/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 20 juillet au 24 juillet 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
27/07/2026
Digital subscription platform brings together the Company’s proprietary consumer health products across consumer (B2C) and corporate (B2B) channels Customers can begin through one of three paths: a free nutritionist [...]
CurePSP Invests in the Next Generation of PSP and CBD Researchers with Student Fellowship Awards
27/07/2026
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- CurePSP has announced its latest student fellowship recipients, totaling seven projects between the Urso Student Fellowship Grant and the Jim Atwood Neuroscience Student [...]
Rose Hill Life Sciences Appoints Jama Pitman as Chief Executive Officer
27/07/2026
Biopharma Veteran and Former Strategic Advisor Steps Up to Lead Organization as Rose Hill Advances Active Clinical Programs in Psychedelic Therapeutics BOSTON, July 27, 2026 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences [...]
Assisting Hands Home Care Frisco Trains Caregivers in Stroke Recovery, Brings Post-Stroke Education to North Texas Families
27/07/2026
Local caregiving expert to address post-stroke fatigue, a symptom families say hospitals rarely warn them about, at Aug. 11 Frisco support group talk Frisco, TEXAS, July 27, 2026 (GLOBE NEWSWIRE) -- Assisting Hands Home [...]
Oktopi secures follow-on funding to expand OktoPilot's AI-informed capabilities, building on the inaugural global health grant
27/07/2026
Grant from the Gates Foundation supports the next phase of work to strengthen OktoPilot's AI-informed capabilities for global health medicine developers MELBOURNE, July 27, 2026 (GLOBE NEWSWIRE) -- Oktopi has received [...]
Zealand Pharma - Transactions related to share buy-back program (week 30, 2026)
27/07/2026
Company announcement No. 35 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 30, 2026) Copenhagen, Denmark, July 27, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Vadma Institute Expands Global Practitioner Certification Program as Interest Grows in Its Neuro-Somatic Wellness Method
27/07/2026
Global certification expansion and preliminary HRV-based observational research mark new milestones for the Vadma neuro somatic method Kevin Libawski performs the Vadma neuro-somatic method on clients. LOS ANGELES, July [...]
Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
27/07/2026
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today provided an update ahead [...]

Pages